We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,530 results
  1. Significant reduction of activity retention in the kidneys via optimized linker sequences in radiohybrid-based minigastrin analogs

    Background

    We recently introduced radiohybrid (rh)-based minigastrin analogs e.g., DOTA-rhCCK-18 (DOTA-D-Dap(p-SiFA)-(D-γ-Glu) 8 -Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH...

    Nadine Holzleitner, Sebastian Fischer, ... Thomas Günther in EJNMMI Research
    Article Open access 02 March 2024
  2. Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs

    Background

    Over the last years, several strategies have been reported to improve the metabolic stability of minigastrin analogs. However, currently...

    Nadine Holzleitner, Thomas Günther, ... Hans-Jürgen Wester in EJNMMI Research
    Article Open access 08 July 2023
  3. Synthesis and preclinical evaluation of novel 99mTc-labeled PSMA ligands for radioguided surgery of prostate cancer

    Background

    Radioguided surgery (RGS) has recently emerged as a valuable new tool in the management of recurrent prostate cancer (PCa). After...

    Jan-Philip Kunert, Max Müller, ... Hans-Jürgen Wester in EJNMMI Research
    Article Open access 16 January 2023
  4. Postmortem redistribution of drugs: a literature review

    Postmortem drug analysis is crucial in identifying the potential cause and manner of death. However, it is threatened by a significant phenomenon...

    Ghadeer M. M. Abdelaal, Nagah I. Hegazy, ... Ghada E. A. Elmesallamy in Forensic Science, Medicine and Pathology
    Article Open access 16 September 2023
  5. Development of a novel 18F-labeled small molecule probe for PET imaging of mesenchymal epithelial transition receptor expression

    Abstract

    The mesenchymal epithelial transition factor (c-Met) is frequently overexpressed in numerous cancers and has served as a validated anticancer...

    Lihong Bu, **aowei Ma, ... Zhen Cheng in European Journal of Nuclear Medicine and Molecular Imaging
    Article 09 November 2023
  6. Development and first-in-human study of PSMA-targeted PET tracers with improved pharmacokinetic properties

    Purpose

    A series of new 68 Ga-labeled tracers based on [ 68 Ga]Ga-PSMA-617 were developed to augment the tumor-to-kidney ratio and reduce the activity...

    Haodong Hou, Yuan Pan, ... Feng Gao in European Journal of Nuclear Medicine and Molecular Imaging
    Article 29 April 2024
  7. Predictive Potential of Acido-Basic Properties, Solubility and Food on Bioequivalence Study Outcome: Analysis of 128 Studies

    Background and Objectives

    Risk assessment related to bioequivalence study outcome is critical for effective planning from the early stage of drug...

    Dejan Krajcar, Rebeka Jereb, ... Iztok Grabnar in Drugs in R&D
    Article Open access 10 June 2023
  8. Synthesis and preclinical evaluation of novel 18F-vancomycin-based tracers for the detection of bacterial infections using positron emission tomography

    Introduction

    Bacterial infections are a major problem in medicine, and the rapid and accurate detection of such infections is essential for optimal...

    G. B. Spoelstra, S. N. Blok, ... P. H. Elsinga in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 22 April 2024
  9. 99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications

    Background

    In recent years, fibroblast activating protein (FAP), a biomarker overexpressed by cancer-associated fibroblasts, has emerged as one of the...

    Alessandra Boschi, Luca Urso, ... Luca Filippi in EJNMMI Radiopharmacy and Chemistry
    Article Open access 02 May 2024
  10. Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA

    Purpose

    The fibroblast activation protein (FAP) is an emerging target for molecular imaging and therapy in cancer. OncoFAP is a novel small organic...

    P. Backhaus, F. Gierse, ... M. Schäfers in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 27 December 2021
  11. Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult Patients

    Background and Objective

    Naftifine, an allylamine, is highly effective against tinea pedis and exhibits relatively greater affinity to skin and nail...

    Shubhadeep D. Sinha, Avula Rajamma, ... Srinivas Reddy Devireddy in Clinical Drug Investigation
    Article 18 July 2023
  12. The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications

    Confirming drug imputability is an important step in the management of cutaneous adverse drug reactions (CADR). Re-challenge is inconvenient and in...

    Carina M. Woodruff, Nina Botto in Clinical Reviews in Allergy & Immunology
    Article Open access 03 February 2022
  13. Translocator protein (18 kDa) positron emission tomography imaging as a biomarker of neuroinflammation in epilepsy

    Increasing evidence indicate that neuroinflammation triggered by glial cells plays a significant role in epileptogenesis. To this effect, the...

    Li Qin, Ling **ao, ... Li Feng in Neurological Sciences
    Article 16 June 2024
  14. Predictions of Bedaquiline Central Nervous System Exposure in Patients with Tuberculosis Meningitis Using Physiologically based Pharmacokinetic Modeling

    Background and Objective

    The use of bedaquiline as a treatment option for drug-resistant tuberculosis meningitis (TBM) is of interest to address the...

    Krina Mehta, Pavel Balazki, ... J. G. Coen van Hasselt in Clinical Pharmacokinetics
    Article Open access 26 March 2024
  15. Synthesis and Biological Evaluation of [18F]FECNT-d4 as a Novel PET Agent for Dopamine Transporter Imaging

    Purpose

    The dopamine transporter (DAT) is a marker of the occurrence and development of Parkinson’s disease (PD) and other diseases with nigrostriatal...

    Shanshan Cao, Jie Tang, ... Zheng** Chen in Molecular Imaging and Biology
    Article 13 April 2021
  16. Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity

    Background

    Several radiolabeled prostate-specific membrane antigen (PSMA) inhibitors based on the lysine-urea-glutamate (KuE) motif as the...

    Martina Wirtz, Alexander Schmidt, ... Hans-Jürgen Wester in EJNMMI Research
    Article Open access 22 August 2018
  17. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy

    Purpose

    A series of radiotracers targeting fibroblast activation protein (FAP) with great pharmacokinetics have been developed for cancer diagnosis...

    Tianhong Yang, Lei Peng, ... Zhihao Zha in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 03 March 2023
  18. Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET

    Background

    The brain is a challenging target for antibody-based positron emission tomography (immunoPET) imaging due to the restricted access of...

    Eva Schlein, Johanna Rokka, ... Jonas Eriksson in EJNMMI Radiopharmacy and Chemistry
    Article Open access 06 March 2024
  19. Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?

    Aim

    Elevated kidney uptake in insulinoma patients remains a major limitation of radiometallated exendin-derived ligands of the glucagon-like peptide 1...

    Veronika Barbara Felber, Hans-Jürgen Wester in EJNMMI Radiopharmacy and Chemistry
    Article Open access 25 August 2021
Did you find what you were looking for? Share feedback.